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Abstract
Background: SAMHD1 counteracts HIV-1 or HIV-2/SIVsmm that lacks Vpx by depleting the intracellular pool of
nucleotides in myeloid cells and CD4+ quiescent T cells, thereby inhibiting the synthesis of retroviral DNA by
reverse transcriptase. Depletion of nucleotides has been shown to underline the establishment of quiescence in
certain cellular systems. These observations led us to investigate whether SAMHD1 could control the transition
between proliferation and quiescence using the THP-1 cell model.
Findings: The entry of dividing THP-1 myeloid cells into a non-dividing differentiated state was monitored after
addition of phorbol-12-myristate-13-acetate (PMA), an inducer of differentiation. Under PMA treatment, cells
overexpressing SAMHD1 display stronger and faster adhesion to their support, compared to cells expressing a
catalytically inactive form of SAMHD1, or cells depleted of SAMHD1, which appear less differentiated. After PMA
removal, cells overexpressing SAMHD1 maintain low levels of cyclin A, in contrast to other cell lines. Interestingly,
SAMHD1 overexpression slightly increases cell adhesion even in the absence of the differentiation inducer PMA.
Finally, we found that levels of SAMHD1 are reduced in proliferating primary CD4+ T cells after T cell receptor
activation, suggesting that SAMHD1 may also be involved in the transition from a quiescent state to a dividing
state in primary T cells.
Conclusions: Altogether, we provide evidence that SAMHD1 may facilitate some aspects of THP-1 cell differentiation.
Restriction of HIV-1 by SAMHD1 may rely upon its ability to modify cell cycle parameters, in addition to the direct
inhibition of reverse transcription.
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Findings
Immune quiescent cells display reduced susceptibility
to HIV-1 productive infection, due to several
quiescence-related phenomena such as cytoskeleton
organization or low viral transcription. The activity of
several restriction factors also contributes to viral in-
hibition by blocking specific steps of the viral life
cycle. Among them, sterile alpha motif and HD-
domain containing protein 1 (SAMHD1) inhibits both
HIV-1 and Vpx-deleted HIV-2/SIVsmm viruses at the
level of reverse transcription [1, 2]. SAMHD1 reduces
the intracellular pool of dNTP through its dNTP
hydrolase activity in myeloid and quiescent CD4+ T
cells [3–7]. Recent studies report that SAMHD1 also
has an RNase activity targeting HIV-1 genomic RNA
[8]. The dNTPase activity of the protein is dependent
on an intact phosphodiesterase HD domain [1, 2].
Though HIV-1 is sensitive to SAMHD1, it has not
developed a viral weapon to counteract this hin-
drance. In contrast, HIV-2/SIVsmm encodes for the
Vpx auxiliary protein, which induces SAMHD1
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degradation by hijacking the Cul4A-DDB1 ubiquitin
ligase through DCAF1 binding [1, 2].
Several reports point to a role of SAMHD1 in tumori-
genesis and in cell cycle progression. In particular,
SAMHD1 has been found mutated in chronic lympho-
cytic leukemia (CLL) [9]. In CLL patient cells, SAMHD1
expression is often reduced as it is the case in several
cancer cell lines [9]. Whole sequencing has also sug-
gested that SAMHD1 could be mutated in malignancies
[10]. Regarding cell cycle progression, proliferation in
HeLa cells is favored by the dNTPase defective
SAMHD1 HD/AA mutant [9]. In fibroblasts, SAMHD1
has been shown to be variously expressed along the cell
cycle, maximally during quiescence and minimally dur-
ing S-phase, which correlates with the need for dNTP
during DNA replication [11]. Apart from SAMHD1, sev-
eral reports suggest that suppression of nucleotide metab-
olism underlines the establishment of a quiescent state
and promotes genomic instability [12–14]. Altogether, we
brought up the hypothesis that SAMHD1 may facilitate
the entry into or the maintenance of quiescence. To test
our hypothesis, we used suspension cultures of the mono-
cytic cell line THP-1 that differentiate into a macrophage-
like phenotype under phorbol-12-myristate-13-acetate
(PMA) treatment and therefore transit from a dividing
state to a quiescent state. PMA-induced differentiation of
Fig. 1 SAMHD1 overexpression promotes PMA-induced differentiation-related morphological phenotype of THP-1 cells. THP-1 control cells and
monoclonal cell lines stably expressing HA-tagged SAMHD1 (wild-type or the HD/AA catalytically inactive mutant) or shRNA targeting SAMHD1
were differentiated by addition of 65 nM of PMA in the culture medium (2.10^5 cells/ml). 24 h after PMA removal, cells were left in PMA-free
medium for several days. (a) Cell morphology was observed with a Zeiss 5 microscope (Gx20). The pictures shown here were taken 72 h after
PMA addition. The results are representative of three independent experiments. (b) For each cell line, cytoplasmic extensions of cells 72 h after
PMA addition were counted and normalized with regards to cell numbers (approximately 300 cells in each condition). The cytoplasmic extensions
ratios obtained result from two independent experiments
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THP-1 cells results, among other things, in cell morpho-
logical changes, adhesion to the plastic surface and ex-
pression of macrophage surface markers such as CD11a,
CD11b and ICAM1 [15, 16]. In addition, THP-1 cells ac-
quire the ability to restrict HIV infection along
differentiation, following SAMHD1 dephosphorylation on
a specific threonine [17–19].
We established THP-1 myeloid cell lines stably overex-
pressing HA-tagged wt SAMHD1 or the catalytic mutant
form of the protein (HD/AA, referred to SAMHD1μ on
the figures) or cells depleted of SAMHD1 (shSAMHD1).
As previously reported, the promoter from the pLenti vec-
tor used for SAMHD1 expression is sensitive to PMA [4].
In the absence of PMA, exogenous SAMHD1 is poorly
expressed, while in PMA-treated cells, levels of SAMHD1
and SAMHD1 HD/AA increased equally (Additional file 1:
Figure S1A).
PMA-mediated THP-1 differentiation is visible under
the microscope with the appearance of multiple mor-
phological changes, including the transition from a
round shape to a fibroblast-like shape, the appearance of
membrane extensions and cell adhesion to the support
Fig. 2 SAMHD1 overexpression increases differentiation-associated adhesion of cells. Equal numbers of cells from each Cell line described in Fig. 1
were tested for their ability to adhere in the presence (a) or absence (b) of the PMA differentiation-inducer, using the xCELLigence apparatus. Three
independant experiments were conducted, two of them are shown. (c) The slopes of the curves during the adhesion process in (a) and (b) (from 0 to
1 h) were calculated for all cell lines in both experiments
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(Additional file 2: Figure S2). Following PMA treatment,
cells stably expressing HA-tagged SAMHD1 displayed a
fibroblast-like shape and multiple extensions faster than
control cells (Ctrl) or cells depleted of SAMHD1
(shSAMHD1) that remained in a round shape (Fig. 1a
and Additional file 2: Figure S2 for the kinetics of these
changes). Cells stably expressing the HD/AA mutant
had an intermediate phenotype. For each cell line we
counted the cytoplasmic extensions appearing over time
after PMA-induced differentiation. Determination of the
ratios between the number of extensions and the
number of cells in each condition showed an increase of
differentiation-associated cytoplasmic extensions in cells
overexpressing HA-SAMHD1 compared to control cells
(Fig. 1b). As suspected, cells overexpressing the HD/AA
catalytic mutant showed an intermediary phenotype,
with more extensions than control cells but less than
cells overexpressing the wild-type protein. As a corollary,
SAMHD1 depleted cells displayed less of these
extensions.
Cell adhesion was monitored using the xCELLigence
system developed by ACEA Biosciences, which relies on
Fig. 3 SAMHD1 overexpression contributes to maintain low levels of cyclin A following PMA-induced differentiation. Cell lines described in Fig. 1
received (or not) a 65 nM PMA treatment for 24 h, then were distributed in 6-well plates. Cells were lysed at the indicated times (from day 0 to
day 5 of differentiation). Western-blot analysis of two markers was conducted in whole cell extracts: Cyclin A (a), whose quantification
levels compared to GAPDH are shown in (b), and the macrophage differentiation marker CD11b (c). The results are representative of two
independent experiments
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the measurement of electrical impedance of the cell
population by micro-electronic biosensors in a plastic
well over time [20]. Two parameters reflect fast and
strong adhesion: a high slope of the line < impedance = a
(time) + b > at the beginning of the measure and a high
cell index providing that cells are plated at the same
density. Cells overexpressing wt SAMHD1 adhered to
the support after PMA addition faster than control cells,
SAMHD1 HD/AA expressing cells and SAMHD1 de-
pleted cells whose impedance levels were slightly de-
creased (Fig. 2a, 2 distinct experiments shown). Same
results were obtained with three different clones for each
cell line (data not shown and Additional file 1:Figure S1
B for the analysis of the selected clones by western blot).
In agreement with these observations, the slope of the
line during the first hour of adhesion was higher in cells
where SAMHD1 was overexpressed (Fig. 2c). Import-
antly, SAMHD1 HD/AA overexpression had no effect
on the increase of cell adhesion, though it was expressed
as well as the wild type protein (see western blot Add-
itional file 1: Figure S1). Finally SAMHD1-depleted cells
adhered in a reproducible way a little bit less efficiently
than control cells, suggesting that endogenous SAMHD1
could also facilitate differentiation (Fig. 2a).
To our surprise, even in the absence of PMA, a small in-
crease in adhesion capability was detected in SAMHD1
overexpressing cells (Fig. 2b and c). This increase was re-
producible but in some experiments was transient (Fig. 2b,
Exp. 2) and, in any case, less efficient than in PMA-treated
cells (Fig. 2c). Nonetheless, overexpression of wt SAMHD1
was not sufficient to induce cell differentiation or to confer
a differentiation-associated restriction phenotype against
HIV to dividing THP-1 cells (without PMA), while it can
increase restriction when the cells were differentiated in
the presence of PMA (data not shown and [21]).
We further analyzed expression of cell cycle (Cyclin A)
and differentiation (CD11b) markers following PMA treat-
ment. Cyclin A is a classical cyclin, whose levels fluctuate
during cell cycle progression, being up in S and G2 phases
and down from early mitosis to the end of G1 and in non-
dividing cells [22]. Two to four days after PMA treatment,
cyclin A levels remained high in wt THP-1 cells and
SAMHD1-depleted cells, but stayed low in SAMHD1
over-expressing cells (Fig. 3a, b and Additional file 3:
Figure S3 for a second experiment). No final conclusion
could be drawn with SAMHD1 HD/AA cells, in which
cyclin A levels did not always fluctuate in the same direc-
tion (Fig. 3a, b and Additional file 3: Figure S3). These re-
sults further suggest that SAMHD1 could facilitate the
quiescent state, though it is unclear whether it depends on
the enzymatic activity of the protein. CD11b was also ana-
lyzed as a marker of differentiation [15, 16]. The kinetics
of CD11b appearance did not significantly change with
SAMHD1 over-expression or extinction (Fig. 3c).
Quiescence and differentiation are intimately linked
when treating THP-1 cells with PMA. On the one
hand entry into quiescence is induced by cellular dif-
ferentiation. On the other hand, SAMHD1 overex-
pression may help to maintain a quiescent state that
facilitates differentiation. Further work is needed to
unravel the exact mechanism by which SAMHD1 im-
pacts this transition process. A distinct relevant
model to study transition from quiescence to prolifer-
ation per se is provided by primary CD4+ T cells,
which transit from a quiescent state to a dividing
state following activation. This activation process cor-
relates with enhanced cell permissivity to HIV-1 in-
fection and with SAMHD1 phosphorylation [6, 7, 17,
23–25]. We hypothesized that SAMHD1 may contrib-
ute to maintain CD4+ T cells in a quiescent state. In
support of this hypothesis, we found that SAMHD1
expression is reduced along T-cell activation (Fig. 4)
in agreement with recent studies [23]. Future work
should aim to analyze whether SAMHD1 overexpres-
sion in quiescent CD4+ T cells would delay entry into
cell cycle following T cell activation and whether the
lentiviral accessory protein Vpx, on the contrary, by
triggering SAMHD1 degradation, could accelerate the
activation process. We speculate that SAMHD1-
mediated restriction finds support in its ability to
modify cell cycle parameters, in addition to the direct
inhibition of reverse transcription.
Fig. 4 Reduction of SAMHD1 expression after T cell activation. Total
peripheral blood CD3+ or CD4+ T cells (extracted from peripheral blood
mononuclear cells with BD Bioscience CD3+ or CD4+ negative-selection
kit, respectively) were activated by incubation with CD3/CD28 beads
(1bead/5cells). Total SAMHD1 levels were assessed in whole cell extracts
by western-blot at 0 (T0), 4 (T1) 8 (T2), 24 (T3), 36 (T4), 48 (T5), 72 (T6)
hours after activation (top) and normalized to GAPDH for quantification
(bottom). One representative experiment among three is shown
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Additional files
Additional file 1: Figure S1. Expression of endogenous and exogenous
SAMHD1 in the different cell lines. THP-1 cells transduced with lentiviral
vectors expressing HA-tagged SAMHD1 wt, SAMHD1 HD/AA mutant, or
shRNA targeting SAMHD1 mRNA were clonally selected under puromycin
treatment (2 μg/ml) for two weeks. (A) Expression of HA-SAMHD1 or
endogenous SAMHD1 is shown for clones 25 (HA-SAMHD1 wt), 14
(HA-SAMHD1 HD/AA) and 4 (shSAMHD1) that were chosen for the results
presented in this manuscript. (B) The results of all the experiments were
reproducible with distinct monoclonal cell lines (blue boxes). (PDF 466 kb)
Additional file 2: Figure S2. Kinetics of cell morphological changes
after PMA addition in the different THP-1 cell lines. Cell lines shown in
Fig. 1, differentiated by PMA treatment for 24 h, were observed with a
Zeiss 5 microscope (Gx20). Pictures were taken at the indicated times
after treatment with PMA. (PDF 610 kb)
Additional file 3: Figure S3. Cyclin A level fluctuations after PMA
treatment in the different THP-1 cell lines. This figure shows a second
independent experiment as the one presented in Fig. 3 a and b.
Western-blot assessment of cyclin A and GADPH levels at the indicated
times was conducted (A) and quantification was performed (B).
(PDF 280 kb)
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